missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ LRFN1 Monoclonal Antibody (610712)
Mouse Monoclonal Antibody
Brand: Invitrogen™ MA561578
This item is not returnable.
View return policy
Description
Reconstitute with sterile PBS to a final concentration of 0.5 mg/mL.
LRFN1 is one of a family of five transmembrane glycoproteins that are highly expressed in neuronal tissues. LRFN proteins share leucine-rich repeat (LRR)-immunoglobulin-like (Ig)-fibronectin type III (Fn)-transmembrane domain structure with other members of the LRR-Ig-Fn protein superfamily such as the Slitrk family of proteins. Expression of LRFN1, -3, and -4 mRNA was detected in embryonic neuronal cells, while Lrfn2 and Lrfn5 expression was primarily restricted to more mature cells. LRFN1, -2, and -4 bound to PDZ domains of postsynaptic PSD95, re-distributing PSD95 to the cell periphery. It has been suggested that the Lrfn proteins play a role in the developing and/or mature vertebrate nervous system. At least two isoforms of LRFN1 are known to exist.
Specifications
| LRFN1 | |
| Monoclonal | |
| 0.5 mg/mL | |
| PBS with trehalose and no preservative | |
| Q9P244 | |
| LRFN1 | |
| Chinese hamster ovary cell line CHO-derived recombinant human SALM2, Gln32-Gly534 (predicted). | |
| 100 μg | |
| Primary | |
| Human | |
| Antibody | |
| IgG2b |
| Immunohistochemistry (Paraffin) | |
| 610712 | |
| Unconjugated | |
| LRFN1 | |
| BC004018; CTC-246B18.8; KIAA1484; leucine rich repeat and fibronectin type III domain containing 1; leucine-rich repeat and fibronectin type III domain-containing protein 1; Lrfn1; Salm2; Semo1; Synaptic adhesion-like molecule 2; synaptic differentiation enhancing molecule 1; synaptic differentiation-enhancing molecule 1 | |
| Mouse | |
| Protein A/G | |
| RUO | |
| 57622 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Lyophilized |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction